Metabolism and the Activity of the Autonomic Nervous System in Patients With Paroxystic Sympathetic Hyperactivity, PSH

NCT03441009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-09-24

No results posted yet for this study

Summary

Adult patients suffering from acquired brain damage run the risk of developing PSH. This group of patients is admitted to our unit, the Neurointensive Stepdown Unit, at Silkeborg Regional Hospital for intensive care and early neurorehabilitation. After weaning from intensive carethey are transferred to Hammel NeuroCentre.

Aim is to assess whether HRV-derived variables in the frequency domain mirror therapeutic and/or nursing and/or pharmacologic interventions. To the extent clinically available BRS and metabolism are included in the assessment.

Conditions

  • Autonomic Nervous System Imbalance

Interventions

OTHER

Physio-/occupational therapy

Physio-/occupational therapy, ADL

Sponsors & Collaborators

  • Region MidtJylland Denmark

    lead OTHER

Principal Investigators

  • Jørgen Feldbæk, Professor · Hammel Neuro- and Research Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-02
Primary Completion
2020-10-01
Completion
2020-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03441009 on ClinicalTrials.gov